Press Releases
Keyword Search
07.13.15
Fluidigm and OpGen Enter Into Strategic Agreement to Develop Multi-Drug Resistance Testing Kits and Equipment
06.17.15
OpGen Reports First Quarter Financial Results and Provides Business Update
06.11.15
OpGen, Inc. Announces Timing for First Quarter Financial Results and Conference Call
06.02.15
OpGen Releases Next-Generation Molecular Testing and Bioinformatics Solution for Combating Multi-Drug Resistant Infections
05.27.15
OpGen's Acuitas(R) MDRO Gene Tests and Bioinformatics Data to be Presented at ASM2015
05.05.15
OpGen Announces Pricing of Initial Public Offering
04.29.15
OpGen’s Acuitas® MDRO Gene Test Data Presented at 25th European Congress of Clinical Microbiology and Infectious Diseases
04.20.15
OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer
03.03.15
OpGen Files Registration Statement for Proposed Initial Public Offering
10.20.14
Hitachi High-Technologies Corporation and OpGen Announce Early Access Program for Human Chromosome Mapping Analytical Service